Pressure-relieving interventions for treating diabetic foot ulcers
Lewis, Jane E. A.
Cochrane Collaboration / Wiley
MetadataShow full item record
Background Diabetes-related foot ulceration is a major contributor to morbidity in diabetes. Diabetic foot ulcers are partly a consequence of abnormal foot pressures and pressure relief is a widely used treatment for healing diabetes-related plantar foot ulcers, but the most effective method for healing is unclear. Objectives To determine the effects of pressure-relieving interventions on the healing of foot ulcers in people with diabetes. Search methods For this update we searched the Cochrane Wounds Group Specialised Register (searched 2 November 2012); The Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2012, Issue 10); Ovid MEDLINE (1950 to October Week 4 2012); Ovid MEDLINE (In-Process & Other Non-Indexed Citations, October 31, 2012); Ovid EMBASE (1980 to 2012 Week 43); and EBSCO CINAHL (1982 to 1 November 2012). There were no restrictions based on language or publication status. Selection criteria Randomised controlled trials evaluating the effects of pressure-relieving interventions on the healing of foot ulcers in people with diabetes. Data collection and analysis Data from eligible trials were extracted, and summarised using a data extraction sheet, by two review authors independently. Main results Fourteen trials (709 participants) met the inclusion criteria for the review. One study compared two different types of non-removable casts with no discernable difference between the groups. Seven studies (366 participants) compared non-removable casts with removable pressure-relieving devices. In five of those studies non-removable casts were associated with a statistically significant increase in the number of ulcers healed compared with the removable device (RR 1.17 95% CI 1.01 to 1.36: P value = 0.04). Two studies (98 participants) found that significantly more ulcers healed with non-removable casts than with dressings alone. Achilles tendon lengthening combined with a non-removable cast in one study resulted in significantly more healed ulcers at 7 months than non-removable cast alone (RR 2.23; 95% CI 1.32 to 3.76). More ulcers remained healed at two years in this group (RR 3.41; 95% CI 1.42 to 8.18). Other comparisons included surgical debridement of ulcers; felt fitted to the foot; felted foam dressings and none of these showed a statistically significant treatment effect in favour of the intervention. Authors' conclusions Non-removable, pressure-relieving casts are more effective in healing diabetes related plantar foot ulcers than removable casts, or dressings alone. Non-removable devices, when combined with Achilles tendon lengthening were more successful in one forefoot ulcer study than the use of a non-removable cast alone.
Cochrane Database of Systematic Reviews
Lewis, J. & Lipp, A.(2013) 'Pressure-relieving interventions for treating diabetic foot ulcers', Cochrane Database of Systematic Reviews, Issue 1. Art. No.: CD002302
This article was published in Cochrane Database of Systematic Reviews in 2013, available at http://dx.doi.org/10.1002/14651858.CD002302.pub2
Showing items related by title, author, subject and abstract.
Effect of Manuka honey on IL-8 secretion in HDFa and the role of transcription factor activator protein (Ap-1) in inflammatory response Majeed, Dhuha (Cardiff Metropolitan University, 2017-06-01)Wound healing is a biological process function to aid in the reduction of blood loss in the incidence of an injury. It involves four complex phases and they are: haemostasis, inflammation, proliferation and ends with ...
The Inflammatory Effect of Manuka Honey and Methylglyoxal on Primary Human Fibroblast Cells through the Production of Interleukin-6. Fletcher, Sean (Cardiff Metropolitan University, 2017-06-01)Introduction: The delayed wound healing process in patients suffering from a diabetic foot ulcer is a serious problem that costs the NHS between £639 million to £662 million a year. The wound healing process is defined by ...
Peroxisome proliferator-activated receptor-gamma agonists in atherosclerosis: current evidence and future directions Roberts, A.W.; Thomas, Andrew; Rees, A.; Evans, M. (Lippencott Williams and Wilkins, 2003-12-01)Purpose of review: The prevalence of type 2 diabetes globally is reaching epidemic proportions. Type 2 diabetes is strongly associated with increased risk of cardiovascular disease. Atherosclerosis is thought to arise as ...